Résultats de la recherche - 7 results
A comparison of COVID-19 incidence rates across six European countries in 2021.
between surveillance systems were detected. Results showed wide variations in testing rates, access to free testing and the types of tests recorded in national databases, which may substantially limit ...
SARS-CoV-2 Surveillance in Belgian Wastewaters
Correlation public health authority SARS-CoV-2 Surveillance viral load per capita viral to faecal ratio wastewater-based epidemiology Abstract: Wastewater-based surveillance was conducted by the national public ...
The Relation between Perceived and Actual Understanding and Adherence: Results from a National Survey on COVID-19 Measures in Belgium.
Publication Type: Peer reviewed scientific article Authors: Vanderplanken, Kirsten; Van den Broucke, Stephan; Aujoulat, Isabelle; Joris Van Loenhout Source: Int J Environ Res Public Health, Volume 18, Issue 19 (2021) Keywords: Belgium COVID-19 cross-secti ...
Closing schools for SARS-CoV-2: a pragmatic rapid recommendation
experts, clinicians and researchers, produced this recommendation in compliance with the standards for trustworthy rapid guidelines. The recommendation is based on data collected through national ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
from the national influenza surveillance networks in Belgium during the winter seasons of 2015-20. Respiratory specimens were collected through the severe acute respiratory infection (SARI) and the ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
n-Plasma is a multicentre nation-wide, randomized, open-label, phase II proof-of-concept clinical trial, evaluating the clinical efficacy and safety of the addition of convalescent plasma to the standard of ...
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
combined to create composite indicators of vulnerability for rapid assessments, in this case to severe health consequences from COVID-19. Countries with available results for sub-national regions within ...